Many generic manufacturers of reproductive health supplies struggle to break into new markets. They initiate and successfully complete WHO prequalification or other quality assurance processes, and invest significant amounts of...
Categories: Advocacy and Accountability Working Group
Three thousand intra-uterine devices (IUDs) have been saved from possible expiry and non-use—yielding more than $2,000 in cost savings and in human terms, averting an estimated 1,993 unwanted pregnancies. This transfer was made...
A new resource offers procurement groups guidance on quality standards and performance specifications for pregnancy tests. The document, “Quality and Performance Guidance on Selection of Pregnancy Tests for Procurement,” was...
Categories: Market Development Approaches Working Group
An Innovation Fund-supported project in China set out to partner with two hospitals to train their doctors in providing young people with Long Acting Reversible Contraceptives (LARCs). But project leader MSI China, supported by a team of experts, surpassed the original plan and signed agreements with six pilot hospitals instead.
Professional health association support and prior registration for obstetric use were found to be critical factors in securing national regulatory approval of misoprostol and mifepristone for medical abortion, a new study has found.